Dichrocepholide B - Compound Card

Dichrocepholide B

Select a section from the left sidebar

Dichrocepholide B

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Sesquiterpene Lactone
Canonical Smiles OC[C@@]1(O)C(=O)O[C@@H]2[C@H]1CC[C@@H]([C@]1([C@@]2(C)C(=O)C=C1)O)C
InChI InChI=1S/C15H20O6/c1-8-3-4-9-11(21-12(18)14(9,19)7-16)13(2)10(17)5-6-15(8,13)20/h5-6,8-9,11,16,19-20H,3-4,7H2,1-2H3/t8-,9+,11+,13-,14-,15+/m0/s1
InChIKey LXSZIMHCXDHCLA-JSKDHCJISA-N
Formula C15H20O6
HBA 6
HBD 3
MW 296.32
Rotatable Bonds 1
TPSA 104.06
LogP -0.44
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 21
Formal Charge 0
Fraction CSP3 0.73
Exact Mass 296.13
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Dichrocephala integrifolia Asteraceae Plantae 1573921

Showing of synonyms

  • Morikawa T, Abdel-Halim OB, et al. (2006). Pseudoguaiane-type sesquiterpenes and inhibitors on nitric oxide production from Dichrocephala integrifolia. Tetrahedron,2006,6,6435-6442. [View]
Pubchem: 11594542
Nmrshiftdb2: 70050942

No compound-protein relationship available.

Structure

SMILES: O=C1C=CC(C12)CCCC3C2OC(=O)C3

Level: 0

Mol. Weight: 296.32 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.84
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.78
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.65

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.38
Plasma Protein Binding
47.76
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
3.27
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-1.41
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.53
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.8
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-1.02
Rat (Acute)
2.67
Rat (Chronic Oral)
2.36
Fathead Minnow
3.66
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Toxic
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
359.09
Hydration Free Energy
-13.53
Log(D) at pH=7.4
0.12
Log(P)
-0.36
Log S
-1.5
Log(Vapor Pressure)
-8.86
Melting Point
190.16
pKa Acid
6.51
pKa Basic
5.61
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Liver carboxylesterase 1 P23141 EST1_HUMAN Homo sapiens 3 0.8725
Liver carboxylesterase 1 P23141 EST1_HUMAN Homo sapiens 3 0.8725
Prolyl tripeptidyl peptidase Q7MUW6 PTP_PORGI Porphyromonas gingivalis 3 0.7019
Prolyl tripeptidyl peptidase Q7MUW6 PTP_PORGI Porphyromonas gingivalis 3 0.7019

Download SDF